|
Q1 FY2027
As of Aug 2, 2026
|
Q4 FY2026
As of May 3, 2026
|
Q3 FY2026
As of Feb 1, 2026
|
Q2 FY2026
As of Nov 2, 2025
|
Q1 FY2026
As of Aug 3, 2025
|
Q4 FY2025
As of Apr 27, 2025
|
Q3 FY2025
As of Jan 26, 2025
|
Q2 FY2025
As of Oct 27, 2024
|
Q1 FY2025
As of Jul 28, 2024
|
Q4 FY2024
As of Apr 28, 2024
|
Q3 FY2024
As of Jan 28, 2024
|
Q2 FY2024
As of Oct 29, 2023
|
Q1 FY2024
As of Jul 30, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 29, 2023
|
Q2 FY2023
As of Oct 30, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
Q4 FY2022
As of May 1, 2022
|
Q3 FY2022
As of Jan 30, 2022
|
Q2 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments - rabbi trust | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Short-term notes receivable | ||||||||||||||||||||
| Current income taxes receivable | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant & equipment, net | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Long-term investments - rabbi trust | ||||||||||||||||||||
| Long-term notes receivable | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Lines of credit - current | ||||||||||||||||||||
| Accounts payable - trade | ||||||||||||||||||||
| Accounts payable - capital expenditures | ||||||||||||||||||||
| Operating lease liability - current | ||||||||||||||||||||
| Deferred compensation - current | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued restructuring | ||||||||||||||||||||
| Income taxes payable - current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Line of credit - long-term | ||||||||||||||||||||
| Operating lease liability - long-term | ||||||||||||||||||||
| Income taxes payable - long-term | ||||||||||||||||||||
| Deferred compensation - long-term | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Common stock, $0.05 par value, authorized 40,000,000 shares, issued and outstanding 12,720,717 at August 2, 2026; 12,605,306 at August 3, 2025 and 12,662,784 at May 3, 2026 | ||||||||||||||||||||
| Capital contributed in excess of par value | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
